510(k) Report

510(k) · Cleared

Recalled · Class II · 2016

Dimension Vista Hcys Flex Reagent Cartridge; Protein 1 Calibrator; Protein 1 Control Low, Medium, High

K063206510(k) TraditionalCleared Dec 28, 200666-day reviewClass II21 CFR 862.1377Recalls 3

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Dade Behring, Inc. · LPS Urinary Homocystine (Nonquantitative) Test System

Cleared on Dec 28, 2006 as substantially equivalent to K052788 (Dade Behring, Inc., 2006) and 2 other predicates after a 66-day review. Its family tree reaches back 2 generations to 2000. 1 later device descends from it. It has been recalled 3 times.

Decided
Dec 28, 2006
Review
66 days
Class
Class II
Product code
LPS
Recalls
3
Predicates
3

Its longest line of descent runs back 2 generations to K002852 (2000). 6 ancestors in all, the oldest K992858 (1999). 1 later device descends from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2006: 1 other ancestor2001: 1 other ancestor2000: 1 other ancestor1999: 1 other ancestor2007: 1 descendant clearedK002852 · N/T Protein Control SL · Dade Behring, Inc. · 2000K012468 · Modification to N/T Protein Control SL · Dade Behring, Inc. · 20011995200020052010201520202025
Other ancestors, by generationDescendants, by generation 1 generation back: 2 other ancestors2 generations back: 2 other ancestors 1 generation forward: 1 descendant K012468 · Modification to N/T Protein Control SL · Dade Behring, Inc. · 2001K002852 · N/T Protein Control SL · Dade Behring, Inc. · 20000
  1. Root · 2 generations backK002852 N/T Protein Control SLDade Behring, Inc. · 2000
  2. 1 generation backK012468 Modification to N/T Protein Control SLDade Behring, Inc. · 2001
  3. This deviceK063206 Dimension Vista Hcys Flex Reagent Cartridge; Protein 1 Calibrator…Dade Behring, Inc. · 2006
  4. Descendant · cites it directly · 0 of its ownK062105 Diazyme Creatinine Liquid Reagents AssayDiazyme Laboratories · 2007

Most influential descendants

Showing 1 of 1 · See all
  • K062105Diazyme Creatinine Liquid Reagents AssayDiazyme Laboratories · 2007 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K002852N/T Protein Control SLDade Behring, Inc.2000—
−1K012468Modification to N/T Protein Control SLDade Behring, Inc.2001—
0 (this device)K063206Dimension Vista Hcys Flex Reagent Cartridge; Protein 1 Calibrator; Protein 1…Dade Behring, Inc.2006—
+1K062105Diazyme Creatinine Liquid Reagents AssayDiazyme Laboratories2007—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199910
200010
200110
200610

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200710
FIG. 1 — Lineage of K063206, 2000–2007Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LPS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K052788N Latex Hcy, N Protein Standard SL, N/T Protein Control L/M/H
Summary page 1
…LPS; JIX; JJY Panel: Clinical Chemistry (75) 3. Identification of the Legally Marketed Device: Dade Behring N Latex HCY - K052788 Dade Behring N Protein Standard SL - K012470 Dade Behring N/T Protein Control SL - K012468…
Dade Behring, Inc.20062
*K012470Modification to N Protein Standard SL
Summary page 1
…ical Chemistry (75) 3. Identification of the Legally Marketed Device: Dade Behring N Latex HCY - K052788 Dade Behring N Protein Standard SL - K012470 Dade Behring N/T Protein Control SL - K012468…
Dade Behring, Inc.20011
*K012468Modification to N/T Protein Control SL
Summary page 1
…ally Marketed Device: Dade Behring N Latex HCY - K052788 Dade Behring N Protein Standard SL - K012470 Dade Behring N/T Protein Control SL - K012468 tiU d Dade Behring…
Dade Behring, Inc.2001—

Also cleared against K052788: 2 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K062105Diazyme Creatinine Liquid Reagents AssayDiazyme Laboratories20070

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
May 17, 2016Class IIZ-2241-2016Under Investigation by firmReagent lots # 15243MA and 15243MB shows a reduced stability once opened that does not meet the Instructions For Use claim of seven (7) days. A maximum bias of -37% was observed.
Sep 18, 2013Class IIZ-0541-2014Unknown/Undetermined by firmDimension Vista HCYS lot 13064MA shows erratic recovery of QC and patient samples.
Aug 3, 2012Class IIIZ-0253-2013PackagingCartridges are leaking. The leaking is observed when opening the wrapper that holds the reagent cartridge.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 6 years and passes through 1 company; a new generation was cleared every 5.3 years on median.
  • 3 of the 6 ancestors have a recall of any class.
  • Of its descendants, K062105 (Diazyme Laboratories, 2007) has gone furthest, with 0 descendants of its own.
  • 2 other devices also cite its predicate K052788.

How does its category compare?

All LPS devices

LPS Urinary Homocystine (Nonquantitative) Test System: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LPS

1in 2013

2007: 22008: 22009: 12012: 42013: 1
2007high 4 (2012) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LPS

141in 2012

2012: 141 days median
2007high 141 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LPS

1in 2024

2007: 12011: 12012: 12013: 12018: 12019: 42024: 1
2007high 4 (2019) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LPS

1in 2024

2014: 12015: 22016: 12017: 82021: 12024: 1
2007high 8 (2017) · low 0 (2007)2025

MAUDE reports naming product code LPS, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—10
20082—00
20091—00
20100—00
20110—10
2012414110
20131—10
20140—01
20150—02
20160—01
20170—08
20180—10
20190—40
20200—00
20210—01
20220—00
20230—00
20240—11
20250—00
20260—0—

What is it indicated for?

The HCYS method is an in vitro diagnostic test for the quantitative determination of total homocysteine in human serum, heparinized and EDTA plasma on the Dimension Vista® System. Measurements of homocysteine aid in the diagnosis and treatment of patients suspected of having hyperhomocysteinemia and homocystinuria. PROT1 CAL is an in vitro diagnostic product for the calibration of the C3 Complement (C3), C4 Complement (C4), Homocysteine (HCYS)…

Read the full statement (133 words)

The HCYS method is an in vitro diagnostic test for the quantitative determination of total homocysteine in human serum, heparinized and EDTA plasma on the Dimension Vista® System. Measurements of homocysteine aid in the diagnosis and treatment of patients suspected of having hyperhomocysteinemia and homocystinuria.

PROT1 CAL is an in vitro diagnostic product for the calibration of the C3 Complement (C3), C4 Complement (C4), Homocysteine (HCYS), Immunoglobulin A (IGA), Immunoglobulin G (IGG), Immunoglobulin M(jGM) and Prealbumin / Transthyretin (PREALB) methods on the Dimension Vista System.

PROT1 CON L, M and H are assayed intralaboratory quality controls for assessment of precision and analytical bias in the determination of C3 Complement (C3), C4 Complement (C4), Homocysteine (HCYS), Immunoglobulin A (IGA), Immunoglobulin G (IGG), Immunoglobulin M (IGM) and Prealbumin / Transthyretin (PREALB) on the Dimension Vista®.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K063206: Dimension Vista Hcys Flex Reagent Cartridge; Protein 1 Calibrator; Protein 1 Control Low, Medium, High.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K063206

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026